ALDEYRA THERAPEUTICS INC's ticker is and the CUSIP is 01438T956. A total of 3 filers reported holding ALDEYRA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $138,944 | -58.4% | 20,800 | -47.7% | 0.00% | -100.0% |
| Q2 2023 | $333,922 | -68.9% | 39,800 | -63.2% | 0.00% | -75.0% |
| Q1 2023 | $1,073,433 | +92.5% | 108,100 | +35.0% | 0.00% | +300.0% |
| Q4 2022 | $557,496 | +55649.6% | 80,100 | +80000.0% | 0.00% | – |
| Q3 2022 | $1,000 | -85.7% | 100 | -94.1% | 0.00% | – |
| Q2 2022 | $7,000 | -98.5% | 1,700 | -98.3% | 0.00% | – |
| Q1 2022 | $453,000 | -11.2% | 101,800 | -20.2% | 0.00% | – |
| Q4 2021 | $510,000 | +74.7% | 127,600 | +283.2% | 0.00% | – |
| Q3 2021 | $292,000 | +116.3% | 33,300 | +179.8% | 0.00% | – |
| Q2 2021 | $135,000 | +128.8% | 11,900 | +138.0% | 0.00% | – |
| Q1 2021 | $59,000 | +247.1% | 5,000 | +100.0% | 0.00% | – |
| Q4 2020 | $17,000 | +70.0% | 2,500 | +78.6% | 0.00% | – |
| Q3 2020 | $10,000 | -81.8% | 1,400 | -85.1% | 0.00% | – |
| Q4 2019 | $55,000 | -38.2% | 9,400 | -44.4% | 0.00% | -100.0% |
| Q3 2019 | $89,000 | +53.4% | 16,900 | +76.0% | 0.00% | 0.0% |
| Q2 2019 | $58,000 | -88.2% | 9,600 | -82.4% | 0.00% | -80.0% |
| Q1 2019 | $492,000 | +2794.1% | 54,500 | +4441.7% | 0.01% | – |
| Q3 2018 | $17,000 | – | 1,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,700 | $7,000 | 0.00% |
| SIMPLEX TRADING, LLC | 22,700 | $90,000 | 0.00% |